Development and internal validation of machine learning algorithms for end-stage renal disease risk prediction model of people with type 2 diabetes mellitus and diabetic kidney disease

被引:72
|
作者
Zou, Yutong [1 ,2 ]
Zhao, Lijun [1 ,2 ]
Zhang, Junlin [1 ,2 ]
Wang, Yiting [1 ,2 ]
Wu, Yucheng [1 ,2 ]
Ren, Honghong [1 ,2 ]
Wang, Tingli [1 ,2 ]
Zhang, Rui [1 ,2 ]
Wang, Jiali [1 ,2 ]
Zhao, Yuancheng [1 ,2 ]
Qin, Chunmei [1 ,2 ]
Xu, Huan [3 ]
Li, Lin [3 ]
Chai, Zhonglin [4 ]
Cooper, Mark E. [4 ]
Tong, Nanwei [5 ]
Liu, Fang [1 ,2 ]
机构
[1] Sichuan Univ, Div Nephrol, West China Hosp, 37 Guoxue Alley, Chengdu 610041, Peoples R China
[2] Sichuan Univ, Ctr Diabet & Metab Res, Lab Diabet Kidney Dis, West China Hosp, Chengdu, Peoples R China
[3] Sichuan Univ, Div Pathol, West China Hosp, Chengdu, Peoples R China
[4] Monash Univ, Cent Clin Sch, Dept Diabet, Melbourne, Vic, Australia
[5] Sichuan Univ, Div Endocrinol, West China Hosp, Chengdu, Peoples R China
关键词
Type 2 diabetes mellitus; diabetic kidney disease; end-stage renal disease; risk prediction model; machine learning; ANEMIA; ACTIVATION; ALBUMIN;
D O I
10.1080/0886022X.2022.2056053
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Aims Diabetic kidney disease (DKD) is the most common cause of end-stage renal disease (ESRD) and is associated with increased morbidity and mortality in patients with diabetes. Identification of risk factors involved in the progression of DKD to ESRD is expected to result in early detection and appropriate intervention and improve prognosis. Therefore, this study aimed to establish a risk prediction model for ESRD resulting from DKD in patients with type 2 diabetes mellitus (T2DM). Methods Between January 2008 and July 2019, a total of 390 Chinese patients with T2DM and DKD confirmed by percutaneous renal biopsy were enrolled and followed up for at least 1 year. Four machine learning algorithms (gradient boosting machine, support vector machine, logistic regression, and random forest (RF)) were used to identify the critical clinical and pathological features and to build a risk prediction model for ESRD. Results There were 158 renal outcome events (ESRD) (40.51%) during the 3-year median follow up. The RF algorithm showed the best performance at predicting progression to ESRD, showing the highest AUC (0.90) and ACC (82.65%). The RF algorithm identified five major factors: Cystatin-C, serum albumin (sAlb), hemoglobin (Hb), 24-hour urine urinary total protein, and estimated glomerular filtration rate. A nomogram according to the aforementioned five predictive factors was constructed to predict the incidence of ESRD. Conclusion Machine learning algorithms can efficiently predict the incident ESRD in DKD participants. Compared with the previous models, the importance of sAlb and Hb were highlighted in the current model.
引用
收藏
页码:562 / 570
页数:9
相关论文
共 50 条
  • [41] Risk Prediction of End-Stage Renal Disease in Living Kidney Donors.
    Massie, A.
    Chow, E.
    Segev, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 223 - 223
  • [42] Clinical predictive factors and prediction models for end-stage renal disease in Chinese patients with type 2 diabetes mellitus
    Gao, Yueming
    Shang, Zhi
    Nie, Sheng
    Feng, Songtao
    Wang, Bin
    Li, Zuolin
    Wu, Min
    Wen, Yi
    Xu, Hong
    Weng, Jianping
    Chen, Chunbo
    Liu, Huafeng
    Yang, Qiongqiong
    Li, Hua
    Kong, Yaozhong
    Li, Guisen
    Wan, Qijun
    Zha, Yan
    Hu, Ying
    Xu, Gang
    Shi, Yongjun
    Zhou, Yilun
    Su, Guobin
    Tang, Ying
    Gong, Mengchun
    Fan, Hou Fan
    Liu, Bicheng
    CLINICAL AND TRANSLATIONAL MEDICINE, 2023, 13 (07):
  • [43] MACHINE LEARNING IN PREDICTION OF VULNERABLE OR RESILIENT END-STAGE RENAL DISEASE PATIENTS
    Pedroso, Joao Pedro
    Valente, Maria Joao
    Rocha, Susana
    Coimbra, Susana
    Catarino, Cristina
    Rocha-Pereira, Petronila
    Bronze-Da-Rocha, Elsa
    Carvalho, Marcia
    Oliveira, Jose Gerardo
    Madureira, Jose
    Fernandes, Joao Carlos
    Do Sameiro-Faria, Maria
    Miranda, Vasco
    Belo, Luis
    Santos-Silva, Alice
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 : 580 - 580
  • [44] Diabetes mellitus and systolic dysfunction in end-stage renal disease
    Smalheiser, Stuart
    Hage, Fadi
    De Mattos, Angelo M.
    Zoghbi, Gilbert
    Perry, Gilbert
    Iskandrian, Ami E.
    Aqel, Raed A.
    CIRCULATION, 2006, 114 (18) : 871 - 871
  • [45] End-stage renal disease in people with type 2 diabetes: Systemic manifestations and exercise implications
    Evans, N
    Forsyth, E
    PHYSICAL THERAPY, 2004, 84 (05): : 454 - 463
  • [46] Redox Genetic Risk Score and the Incidence of End-Stage Kidney Disease in People with Type 1 Diabetes
    Mohammedi, Kamel
    Marre, Michel
    Hadjadj, Samy
    Potier, Louis
    Velho, Gilberto
    CELLS, 2022, 11 (24)
  • [47] Establishment and Validation of a Risk Prediction Model for Kidney Prognosis of People with Type 2 Diabetic Kidney Disease Diagnosed by Kidney Biopsy
    Wang Wenjian
    Chen Xiaojie
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [48] Prediction of the risk of developing end-stage renal diseases in newly diagnosed type 2 diabetes mellitus using artificial intelligence algorithms
    Ou, Shuo-Ming
    Tsai, Ming-Tsun
    Lee, Kuo-Hua
    Tseng, Wei-Cheng
    Yang, Chih-Yu
    Chen, Tz-Heng
    Bin, Pin-Jie
    Chen, Tzeng-Ji
    Lin, Yao-Ping
    Sheu, Wayne Huey-Herng
    Chu, Yuan-Chia
    Tarng, Der-Cherng
    BIODATA MINING, 2023, 16 (01)
  • [49] Prediction of the risk of developing end-stage renal diseases in newly diagnosed type 2 diabetes mellitus using artificial intelligence algorithms
    Shuo-Ming Ou
    Ming-Tsun Tsai
    Kuo-Hua Lee
    Wei-Cheng Tseng
    Chih-Yu Yang
    Tz-Heng Chen
    Pin-Jie Bin
    Tzeng-Ji Chen
    Yao-Ping Lin
    Wayne Huey-Herng Sheu
    Yuan-Chia Chu
    Der-Cherng Tarng
    BioData Mining, 16
  • [50] Adherence to medications improves risk reduction of end-stage renal disease in diabetes mellitus
    Chang, P. -Y.
    Chiou, H. -Y.
    Chien, L. -N.
    Li, Y. -L.
    Lin, Y. -F.
    Wang, C. -C.
    Chiu, W. -T.
    DIABETOLOGIA, 2014, 57 : S488 - S488